Lakewood-Amedex Biotherapeutics Inc. (LABT) Operating income 2024–2025
Lakewood-Amedex Biotherapeutics Inc. (LABT) annual operating income history from SEC filings — each fiscal year as reported.
-$3.8MFY2025 · since FY2024: -$4.0M → -$3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.8M | +6.3% |
| FY2024 | -$4.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LABT financial trends
LABT RevenueLABT Net incomeLABT Net marginLABT Gross profitLABT Gross marginLABT Operating marginLABT Operating cash flowLABT Free cash flowLABT Capital expendituresLABT Return on equityLABT Stock buybacksLABT Dividends paidLABT Total assetsLABT Total liabilitiesLABT Shareholders’ equityLABT overview →